Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-20x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -86.33% |
| Q2 2025 | -49.25% |
| Q1 2025 | -29.00% |
| Q4 2024 | 42.15% |
| Q3 2024 | 29.47% |
| Q2 2024 | 34.49% |
| Q1 2024 | 3.75% |
| Q4 2023 | -0.90% |
| Q3 2023 | -4.42% |
| Q2 2023 | -5.60% |
| Q1 2023 | -19.26% |
| Q4 2022 | -3.00% |
| Q3 2022 | 5.70% |
| Q2 2022 | 10.61% |
| Q1 2022 | 8.36% |
| Q4 2021 | 1.84% |
| Q3 2021 | 9.48% |
| Q2 2021 | 17.73% |
| Q1 2021 | 19.85% |
| Q4 2020 | -29.83% |
| Q3 2020 | 4.32% |
| Q2 2020 | 35.25% |
| Q1 2020 | -63.75% |
| Q4 2019 | 14.26% |
| Q3 2019 | 22.19% |
| Q2 2019 | -3.59% |
| Q1 2019 | -19.74% |
| Q4 2018 | 360.12% |
| Q3 2018 | -29.82% |
| Q2 2018 | -8.66% |
| Q1 2018 | -26.38% |
| Q4 2017 | -11.35% |
| Q3 2017 | -19.63% |
| Q2 2017 | -13.31% |
| Q1 2017 | 22.40% |
| Q4 2016 | -5.63% |
| Q3 2016 | -16.65% |
| Q2 2016 | 0.54% |
| Q1 2016 | 27.60% |
| Q4 2015 | 16.73% |